Navigation Links
Joint Replacement Patients Face Blood Clot Risk in Hospital
Date:1/17/2012

By Denise Mann
HealthDay Reporter

TUESDAY, Jan. 17 (HealthDay News) -- One of every 100 people undergoing knee replacement surgery and 1 of 200 people having hip replacement surgery will develop a blood clot before they leave the hospital, even if they take steps to prevent the development of these blood clots, a new evidence review suggests.

A deep venous thrombosis (DVT) or blood clot can form deep within the veins, usually in the leg. The real risk occurs if these blood clots dislodge, travel through your bloodstream, and block blood flow in your lungs, which is called pulmonary embolism.

The new study, published in the Jan. 18 Journal of the American Medical Association, seeks to provide a reliable benchmark of this risk, but many experts in the field worry that the actual risk of blood clots after joint replacement is really much higher than this study suggests.

Researchers led by Jean-Marie Januel, of the Lausanne University Hospital, in Switzerland, analyzed 47 studies comprising nearly 45,000 joint replacement cases. All patients received preventive measures to lower their risk of developing a blood clot. Despite this treatment, one in every 100 patients undergoing knee replacement and 1 in every 200 patients undergoing hip replacement developed a blood clot before hospital discharge. Prevention typically involves getting patients moving soon after surgery, providing compression stockings or boots and administering some type of medication that prevents clots from forming.

Dr. John Heit, a cardiologist at the Mayo Clinic in Rochester, Minn., wrote an editorial accompanying the new report.

"The authors are trying to estimate the magnitude of the problem among patients who receive the most effective prophylaxis available today," Heit said. But the risk is actually much higher than the study suggests, he said. "One has to understand the period of risk extends beyond the duration of hospitalization, which these days, is really quite short."

He added, "Orthopedic surgeons are very aware of this problem and do an excellent job in choosing patients that are most likely to benefit from surgery, and they are very religious in terms of providing some form of prophylaxis after surgery."

Dr. Joel Buchalter, an orthopedic surgeon at Somers Orthopaedic Surgery and Sports Medicine Group in Carmel, N.Y., agreed. He said that the risk of blood clots after joint replacement surgery may be even higher. The new study looked only at patients who developed blood clots in the hospital, but these blood clots can develop weeks after the surgery, he said.

Signs of a blood clot may include swelling, tenderness and pain when flexing the ankle, Buchalter said. "If a person has any of these symptoms, an ultrasound exam can rule a blood clot in or out, but many times blood clots have no symptoms. Some people have a great-looking leg and have a blood clot and don't even know it," he said.

Dr. Mathias Bostrom, an orthopedic surgeon at the Hospital for Special Surgery in New York City, said that the risk for blood clots after a joint replacement is real. "The new study once again reinforces that even in 2012, the risk of blood clots after total knee or hip replacement surgery is significant," Bostrom said. There are many new drugs available today to help lower risk for blood clots after surgery, but these do have risks of their own, he said.

More information

Learn more about deep vein thrombosis at the American Academy of Orthopaedic Surgeons.

SOURCES: John Heit, M.D., cardiologist, Mayo Clinic, Rochester, Minn.; Mathias Bostrom, M.D., orthopedic surgeon, Hospital for Special Surgery, New York City; Joel Scott Buchalter, M.D., orthopedic surgeon, Somers Orthopaedic Surgery and Sports Medicine Group, Carmel, N.Y.; Jan. 18, 2012, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. ATS issues joint statement on key issues and recommendations for critical care research
2. Timing of Aquatic Therapy After Joint Replacement Matters
3. AIUM and AUA develop joint guideline for the performance of an ultrasound examination in urology
4. Patients at risk of knee joint complications when new technology is used
5. Titanium Joint Debris May Trigger Painful Inflammation
6. Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs
7. Studies Suggest Link Between Smog, Joint Disease
8. A new definition for periprosthetic joint infection
9. Race Tied to Risk for Arthritis in Large Joints
10. Joint preservation in osteoarthritis
11. More African-Americans burdened by osteoarthritis in multiple large joints
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Joint Replacement Patients Face Blood Clot Risk in Hospital
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be participating ... Exposition, the event will take place February 23-25, 2017 at the Calvin L. Rampton ... Booth #909 with three new ambulances on display. , “JEMS is ...
(Date:2/18/2017)... (PRWEB) , ... February 17, 2017 , ... ... leading source of disruptive innovation in the industry, according to the recent NEJM ... are based on surveys of the NEJM Catalyst Insights Council, a qualified group ...
(Date:2/18/2017)... ... February 18, 2017 , ... A new ... and contact points to easily connect elderly veterans of America's armed forces to ... funding. It also conveys material on this year's increase in the Veterans Pension ...
(Date:2/17/2017)... ... February 17, 2017 , ... For the ... management solution to the exhibit floor for the 2017 HIMSS Conference & ... From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected at ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth ... most widely used electronic patient signatures solution in healthcare . , Since ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 2017 According to a new market research ... Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End User ... MarketsandMarkets, the market is expected to reach USD 330.6 Million by ... 3.7% from 2016 to 2021. Continue ... ...
(Date:2/17/2017)... 2017 Theravance Biopharma, Inc. (NASDAQ: ... today announced the presentation of positive clinical data ... pan-Janus kinase (JAK) inhibitor designed to be intestinally ... the European Crohn,s and Colitis Organization (ECCO). In ... from its completed Phase 1 study of single-ascending ...
(Date:2/17/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and forecasts ... analysis is provided for these markets. Market data and analytics are derived ...
Breaking Medicine Technology: